<DOC>
	<DOCNO>NCT02416531</DOCNO>
	<brief_summary>Vulvar lichen sclerosus ( VLS ) lymphocyte-mediated disease unknown etiology cause intense itch well stenosis , hinder evacuation urination . It also limit sex life due severe local pruritus , pain dyspareunia ( pain sexual intercourse ) . The standard treatment disease use topical corticosteroid reduce clinical symptom try increase disease-free interval . Photodynamic therapy ( PDT ) , treatment associate light radiation photosensitize agent low-level laser therapy ( LLLT ) therapy promote effective immunomodulatory response application site mean photophysical photochemical phenomenon molecular systemic level , promote use chronic dermatosis . The aim study compare effect PDT , LLLT , topical corticosteroid VLS evaluate clinical , histological , immunohistochemical spectroscopic response . The study prospective , randomize , control , population 60 woman histological diagnosis VLS , enrol outpatient clinic Genitoscopy Department Pérola Byington Hospital São Paulo . There 3 treatment group : PDT , LLLT topical corticosteroid , allocate randomization 20 patient one . The clinical course monitor measure local temperature , itching , clamp ( atrophy ) , appearance lesion . Histologically , slide classified accord Hewitt grade order collagen fiber quantify . Immunohistochemical analysis do use marker IFN-γ , TGF-β , CD4 , CD8 , IL-1 , p53 Ki-67 . Finally , spectroscopic evaluation do reflectance . Descriptive inferential statistical analysis conduct compare group association different response .</brief_summary>
	<brief_title>Vulvar Lichen Sclerosus : Comparison Between Clobetasol Propionate , Photodynamic Therapy Low-Intensity Laser</brief_title>
	<detailed_description>Dosimetry Experimental Groups : There dosimetric protocol establish treatment VLS PDT , LLLT . According literature , energy density range 9 150 J/cm2 power density 40 700 mW/cm2 , mention work report dosimetry use . As , dosimetry use study base pilot clinical study perform group . The patient randomize 3 group 20 patient one : Group GC : Corticosteroid whole vulva . Clobetasol propionate 0.05 % ointment apply daily dose 1 g/application ( 1 g sachet ) 4 week . Group GPDT : Localized photodynamic therapy 8 point vulva . Methylene blue 0.01 % intralesional , λ = 660 ± 10 nm , P = 100 mW , PD = 510 mW/cm2 , E = 4 J , ED = 20 J/cm2 , = 40 , week 4 week . Group GLLLT : Localized low-level laser therapy 8 point vulva . The parameter GPDT , except methylene blue , week 4 week . Analyses : The histological immunohistochemical analysis perform 30 day start treatment , whereas clinical analysis perform weekly treatment day GPDT GLLLT group . The control group see weekly standard treatment perform patient , home , 30 day recommend International Society Study Vulvar Disease ( ISSVD ) . After treatment patient follow verification recorrence one year , minimum .</detailed_description>
	<mesh_term>Lichen Sclerosus et Atrophicus</mesh_term>
	<mesh_term>Vulvar Lichen Sclerosus</mesh_term>
	<mesh_term>Clobetasol</mesh_term>
	<criteria>adult female patient ( age 18 year ) ; vulvar lichen sclerosus diagnose histologically ; normal level cortisol confirm blood test . adult female patient age 18 ; patient kind ongoing cancer and/or AIDS coagulopathy , pregnant breastfeed woman ; patient use corticosteroid , immunosuppressant anticoagulant ; patient renal , hepatic pulmonarycardiovascular failure ; patient undergo kind organ transplantation last three year .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Vulvar lichen sclerosus</keyword>
	<keyword>Photodynamic therapy</keyword>
	<keyword>Low-level laser therapy</keyword>
	<keyword>Clobetasol propionate</keyword>
</DOC>